Abstract:
Nowadays, the prevalence of the cardiovascular disease continuously rises. According to the World Health Organization, the cardiovascular disease is the major cause of the deaths in the world's population. The cause of this disease is due to inappropriate lifestyle and health behavior, resulting in chronic inflammation and ultimately chronic diseases such as diabetes, high blood pressure, and hypercholesterolemia. These diseases are associated with inflammation and risk factors for cardiovascular disease in the future. It has been discovered that Thai herb like turmeric can help reduce inflammation and can be safely used. Thus, it is expected that turmeric extracts can reduce inflammation among people who are at risk for cardiovascular disease.
The objective of this study was to investigate the effect of turmeric extract capsules on inflammation reduction among those are at risk for cardiovascular disease.
For the methodology, this study was a clinical trial. The sample of this study was 12 individuals whom are at risk for cardiovascular disease. Their qualifications meet the assessment criteria of cardiovascular disease risk by the Rama-EGAT Hearth Score. Volunteers were asked to take 1,500 mg of turmeric extracts per day under the condition of daily intake for 4 weeks. The
results were assessed by comparing the average hs-CRP levels in blood between before experiment, 2 weeks after experiment, and end of the research project.
When the research results of all 3 weeks were considered, it was found that hs-CRP levels tended to decrease continuously. In an initial week, the hs-CRP level was 3.071 ± 4.182 mg/L; in the second week, it was 2.727 ± 3.428 mg / L, and in the fourth week, it was 2.619 ± 3.379 mg/L. Moreover, the hs-CRP levels of initial week, 2 weeks, and 4 weeks after experiment had no statistically significant difference (p-value = 0.287) and the side effect of turmeric extracts intake was not found.